← Back to headlines
Thermo Fisher Scientific Partners with AIM ImmunoTech for Phase 3 Cancer Trial
Thermo Fisher Scientific (TMO) has partnered with AIM ImmunoTech to collaborate on a Phase 3 cancer trial, combining their expertise in oncology research.
24 Mar, 14:43 — 24 Mar, 14:43
Sources
Showing 1 of 1 sources
